Works matching DE "TUBERCULOSIS vaccines"
Results: 777
Risk of Mycobacterium tuberculosis infection in Somalia: national tuberculin survey 2006.
- Published in:
- Eastern Mediterranean Health Journal, 2008, v. 14, n. 3, p. 518
- By:
- Publication type:
- Article
TUBERCULOSIS CONTROL: CHALLENGES OF AN ANCIENT AND ONGOING EPIDEMIC.
- Published in:
- Public Health Reports, 2007, v. 122, n. 5, p. 683, doi. 10.1177/003335490712200517
- By:
- Publication type:
- Article
Advisory council calls for development of new vaccines for tuberculosis.
- Published in:
- Public Health Reports, 1998, v. 113, n. 6, p. 485
- Publication type:
- Article
TB vaccine failure was predictable.
- Published in:
- Nature, 2013, v. 503, n. 7477, p. 469, doi. 10.1038/503469e
- By:
- Publication type:
- Article
Vaccines: An age-old problem.
- Published in:
- Nature, 2013, v. 502, n. 7470, p. S8, doi. 10.1038/502S8a
- By:
- Publication type:
- Article
Modern heroes.
- Published in:
- 2011
- Publication type:
- Editorial
A 2020 vision for vaccines against HIV, tuberculosis and malaria.
- Published in:
- Nature, 2011, v. 473, n. 7348, p. 463, doi. 10.1038/nature10124
- By:
- Publication type:
- Article
Immunology: TB vaccine with a long view.
- Published in:
- Nature, 2011, v. 469, n. 7331, p. 446, doi. 10.1038/469446c
- Publication type:
- Article
Lloyd John Old 1933-2011.
- Published in:
- Nature Immunology, 2012, v. 13, n. 2, p. 103, doi. 10.1038/ni.2209
- By:
- Publication type:
- Article
Acoperire vaccinală nesatisfăcătoare pentru vaccinurile incluse în Programul Naţional de Imunizări.
- Published in:
- Medic.ro, 2022, v. 146, n. 2, p. 36
- By:
- Publication type:
- Article
Advancements in Nanoparticle-Based Adjuvants for Enhanced Tuberculosis Vaccination: A Review.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1335, doi. 10.3390/vaccines12121335
- By:
- Publication type:
- Article
Field Trial with Vaccine Candidates Against Bovine Tuberculosis Among Likely Infected Cattle in a Natural Transmission Setting.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1173, doi. 10.3390/vaccines12101173
- By:
- Publication type:
- Article
Mtb -Specific HLA-E-Restricted T Cells Are Induced during Mtb Infection but Not after BCG Administration in Non-Human Primates and Humans.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1129, doi. 10.3390/vaccines12101129
- By:
- Publication type:
- Article
Immunogenicity and Protective Efficacy of a Multi-Antigen Mycobacterium tuberculosis Subunit Vaccine in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 997, doi. 10.3390/vaccines12090997
- By:
- Publication type:
- Article
Trends in Viral Vector-Based Vaccines for Tuberculosis: A Patent Review (2010–2023).
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 876, doi. 10.3390/vaccines12080876
- By:
- Publication type:
- Article
Mycobacterium tuberculosis –Human Immunodeficiency Virus Infection and the Role of T Cells in Protection.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 730, doi. 10.3390/vaccines12070730
- By:
- Publication type:
- Article
Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 530, doi. 10.3390/vaccines12050530
- By:
- Publication type:
- Article
Tuberculosis Vaccines and T Cell Immune Memory.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 483, doi. 10.3390/vaccines12050483
- By:
- Publication type:
- Article
Promising Cytokine Adjuvants for Enhancing Tuberculosis Vaccine Immunity.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 477, doi. 10.3390/vaccines12050477
- By:
- Publication type:
- Article
Lung IL-17A-Producing CD4 + T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 128, doi. 10.3390/vaccines12020128
- By:
- Publication type:
- Article
Enhancing TB Vaccine Efficacy: Current Progress on Vaccines, Adjuvants and Immunization Strategies.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 38, doi. 10.3390/vaccines12010038
- By:
- Publication type:
- Article
Safety and Immunogenicity of an In Vivo Muscle Electroporation Delivery System for DNA- hsp65 Tuberculosis Vaccine in Cynomolgus Monkeys.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1863, doi. 10.3390/vaccines11121863
- By:
- Publication type:
- Article
Comparison of the Immunogenicity and Efficacy of rBCG-EPCP009, BCG Prime-EPCP009 Booster, and EPCP009 Protein Regimens as Tuberculosis Vaccine Candidates.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1738, doi. 10.3390/vaccines11121738
- By:
- Publication type:
- Article
CXCR3 Provides a Competitive Advantage for Retention of Mycobacterium tuberculosis -Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1549, doi. 10.3390/vaccines11101549
- By:
- Publication type:
- Article
Safety and Protective Efficacy of a Candidate Vector-Based Vaccine for Bovine Tuberculosis.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1199, doi. 10.3390/vaccines11071199
- By:
- Publication type:
- Article
Vaccines against Tuberculosis: Where Are We Now?
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1013, doi. 10.3390/vaccines11051013
- By:
- Publication type:
- Article
Non-Specific Effects of Bacillus Calmette-Guérin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 121, doi. 10.3390/vaccines11010121
- By:
- Publication type:
- Article
Therapeutic Potentials of Immunometabolomic Modulations Induced by Tuberculosis Vaccination.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2127, doi. 10.3390/vaccines10122127
- By:
- Publication type:
- Article
Recombinant BCG to Enhance Its Immunomodulatory Activities.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 827, doi. 10.3390/vaccines10050827
- By:
- Publication type:
- Article
Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060831
- By:
- Publication type:
- Article
Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 802, doi. 10.3390/vaccines10050802
- By:
- Publication type:
- Article
Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines.
- Published in:
- Vaccines, 2022, v. 10, n. 3, p. 418, doi. 10.3390/vaccines10030418
- By:
- Publication type:
- Article
Identification of Mycobacterium tuberculosis Antigens with Vaccine Potential Using a Machine Learning-Based Reverse Vaccinology Approach.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1098, doi. 10.3390/vaccines9101098
- By:
- Publication type:
- Article
Adjuvants and Antigen-Delivery Systems for Subunit Vaccines against Tuberculosis.
- Published in:
- Vaccines, 2021, v. 9, n. 9, p. 972, doi. 10.3390/vaccines9090972
- By:
- Publication type:
- Article
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 289, doi. 10.3390/vaccines9030289
- By:
- Publication type:
- Article
Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 245, doi. 10.3390/vaccines9030245
- By:
- Publication type:
- Article
Id3 and Bcl6 Promote the Development of Long-Term Immune Memory Induced by Tuberculosis Subunit Vaccine.
- Published in:
- Vaccines, 2021, v. 9, n. 2, p. 126, doi. 10.3390/vaccines9020126
- By:
- Publication type:
- Article
Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis -Specific Genomic Regions Encoding the ESAT6-like Proteins.
- Published in:
- Vaccines, 2021, v. 9, n. 1, p. 27, doi. 10.3390/vaccines9010027
- By:
- Publication type:
- Article
A Review of Adherence and Predictors of Adherence to the CONSORT Statement in the Reporting of Tuberculosis Vaccine Trials.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 770, doi. 10.3390/vaccines8040770
- By:
- Publication type:
- Article
BCG Provides Short-Term Protection from Experimental Cerebral Malaria in Mice.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 745, doi. 10.3390/vaccines8040745
- By:
- Publication type:
- Article
Fusion Cytokines IL-7-Linker-IL-15 Promote Mycobacterium Tuberculosis Subunit Vaccine to Induce Central Memory like T Cell-Mediated Immunity.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 715, doi. 10.3390/vaccines8040715
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 707, doi. 10.3390/vaccines8040707
- By:
- Publication type:
- Article
Driving Adoption and Commercialization of Subunit Vaccines for Bovine Tuberculosis and Johne's Disease: Policy Choices and Implications for Food Security.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 667, doi. 10.3390/vaccines8040667
- By:
- Publication type:
- Article
Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 652, doi. 10.3390/vaccines8040652
- By:
- Publication type:
- Article
CD4 + T Cells Induced by Tuberculosis Subunit Vaccine H1 Can Improve the HIV-1 Env Humoral Response by Intrastructural Help.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 604, doi. 10.3390/vaccines8040604
- By:
- Publication type:
- Article
An Overview of the Development of New Vaccines for Tuberculosis.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 586, doi. 10.3390/vaccines8040586
- By:
- Publication type:
- Article
Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 378, doi. 10.3390/vaccines8030378
- By:
- Publication type:
- Article
Antigen-Specific IFN-γ/IL-17-Co-Producing CD4+ T-Cells are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 300, doi. 10.3390/vaccines8020300
- By:
- Publication type:
- Article
First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment.
- Published in:
- Vaccines, 2019, v. 7, n. 4, p. 166, doi. 10.3390/vaccines7040166
- By:
- Publication type:
- Article
Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 78, doi. 10.3390/vaccines7030078
- By:
- Publication type:
- Article